Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-2965
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial ; volume:25 ; number:1 ; day:13 ; month:11 ; year:2013 ; pages:385-392 ; date:1.2014
Osteoporosis international ; 25, Heft 1 (13.11.2013), 385-392, 1.2014
- Creator
-
Klop, C.
Vries, F. de
Vinks, T.
Kooij, M. J.
Staa, T. P. van
Bijlsma, J. W. J.
Egberts, A. C. G.
Bouvy, M. L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00198-013-2562-8
- URN
-
urn:nbn:de:101:1-2019101707131274104748
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Klop, C.
- Vries, F. de
- Vinks, T.
- Kooij, M. J.
- Staa, T. P. van
- Bijlsma, J. W. J.
- Egberts, A. C. G.
- Bouvy, M. L.
- SpringerLink (Online service)
Other Objects (12)
Glucocorticoid induced osteoporosis : 12 tables
Glucocorticoid-induced osteoporosis: an update
Osteoporosis prophylaxis in acute SCI
Linking glucocorticoid-induced osteoporosis to osteoimmunology
Pharmacist interventions in osteoporosis management: a systematic review
Zerebrales Glucocorticoid-Feedback bei metabolischen Erkrankungen
Pharmacological Interventions for Glucocorticoid-Induced Osteoporosis: An Umbrella Review
Glucocorticoid-induced osteoporosis—from molecular mechanism to clinical practice
The critical role of T cells in glucocorticoid-induced osteoporosis
Intramembranous ossification and endochondral ossification are impaired differently between glucocorticoid-induced osteoporosis and estrogen deficiency-induced osteoporosis
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis
Association between dietary selenium intake and the prevalence of osteoporosis and its role in the treatment of glucocorticoid-induced osteoporosis
Glucocorticoid induced osteoporosis : 12 tables
Glucocorticoid-induced osteoporosis: an update
Osteoporosis prophylaxis in acute SCI
Linking glucocorticoid-induced osteoporosis to osteoimmunology
Pharmacist interventions in osteoporosis management: a systematic review
Zerebrales Glucocorticoid-Feedback bei metabolischen Erkrankungen
Pharmacological Interventions for Glucocorticoid-Induced Osteoporosis: An Umbrella Review
Glucocorticoid-induced osteoporosis—from molecular mechanism to clinical practice
The critical role of T cells in glucocorticoid-induced osteoporosis
Intramembranous ossification and endochondral ossification are impaired differently between glucocorticoid-induced osteoporosis and estrogen deficiency-induced osteoporosis
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis
Association between dietary selenium intake and the prevalence of osteoporosis and its role in the treatment of glucocorticoid-induced osteoporosis
Glucocorticoid induced osteoporosis : 12 tables
Glucocorticoid-induced osteoporosis: an update
Osteoporosis prophylaxis in acute SCI
Linking glucocorticoid-induced osteoporosis to osteoimmunology
Pharmacist interventions in osteoporosis management: a systematic review
Zerebrales Glucocorticoid-Feedback bei metabolischen Erkrankungen
Pharmacological Interventions for Glucocorticoid-Induced Osteoporosis: An Umbrella Review
Glucocorticoid-induced osteoporosis—from molecular mechanism to clinical practice
The critical role of T cells in glucocorticoid-induced osteoporosis
Intramembranous ossification and endochondral ossification are impaired differently between glucocorticoid-induced osteoporosis and estrogen deficiency-induced osteoporosis
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis